GlaxoSmithKline scientists accused of stealing drug R&D secrets for China scheme

John Carroll Yu Xue had a hard-earned reputation as a top chemist while she was working for GlaxoSmithKline in its Upper Merion, PA, facility. But Yu Xue–better known as Joyce–was ...

FDA snow day delays review of Sarepta’s Duchenne drug

John Carroll FierceBiotech News

Galapagos moves AbbVie-partnered drug into PhI as multipronged attack on CF takes shape

Nick Paul Taylor Galapagos has kicked off a Phase I trial of its AbbVie-partnered cystic fibrosis (CF) drug, GLPG2222. The start of the trial marks another milestone in the rolling ...

Crippled by 2 deaths, Zafgen says obesity drug cut weight in PhIII

John Carroll With its clinical development program for a new obesity drug in limbo following the unexplained deaths of two patients, Zafgen reported today that the troubled Phase III ...

AbbVie and Roche’s cancer drug snags another ‘breakthrough’ tag

Damian Garde AbbVie and Roche's cancer drug venetoclax, awaiting FDA approval, picked up another breakthrough therapy nod from the agency for its potential as part of a combination ...

Lilly and Incyte shoot for FDA approval with an oral RA drug

Damian Garde Partners Eli Lilly and Incyte filed an oral rheumatoid arthritis treatment for FDA approval, hoping to launch an agent that can steal market share from blockbuster injectables. FierceBiotech ...

French drug trial disaster leaves patient dead amid a slew of unanswered questions

Damian Garde The patient left brain-dead in last week's botched drug trial has died, French authorities said, spurring more questions about how a routine Phase I study went awry ...

Acorda bags PhIII Parkinson’s drug in $363M Biotie buyout

John Carroll FierceBiotech News

Eleven Bio faces cash crunch as lead drug flunks another PhIII

John Carroll FierceBiotech News

Syros raises $40M to get its leukemia drug into Phase II

Damian Garde Syros Pharmaceuticals raised $ 40 million in equity to push forward with its pipeline of genetically targeted drugs, securing the cash it needs to take its top prospect ...

Botched drug trial leaves one patient ‘brain-dead,’ 5 hospitalized

Damian Garde A botched Phase I trial has left 6 patients in serious condition with one effectively "brain-dead," according to the French government, which has opened an investigation. FierceBiotech ...

UPDATED: Sarepta shares crash on a harsh FDA review of Duchenne’s drug

John Carroll Sarepta's quest to gain an accelerated approval for eteplirsen was subjected to some harsh scrutiny by regulators at the FDA. And the insiders concluded that much of ...
Page 2 of 4512345...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS